Premium
Aadi Bioscience Inc (AADI)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Show more
Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update PR Newswire LOS ANGELES, Nov. 6, 2024 FYARRO® sales of $7.2 million for Q3 2024, reflecting...
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update PR Newswire LOS ANGELES, Oct. 30, 2024 LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.11 | 4.86725663717 | 2.26 | 2.47 | 2.22 | 60267 | 2.31545637 | CS |
| 4 | 0.41 | 20.9183673469 | 1.96 | 2.47 | 1.95 | 144187 | 2.18125709 | CS |
| 12 | 0.57 | 31.6666666667 | 1.8 | 2.47 | 1.725 | 123263 | 2.0250303 | CS |
| 26 | 0.54 | 29.5081967213 | 1.83 | 2.47 | 1.21 | 210335 | 1.69404156 | CS |
| 52 | -2.7 | -53.2544378698 | 5.07 | 5.54 | 1.21 | 301439 | 2.02187793 | CS |
| 156 | -17.86 | -88.284725655 | 20.23 | 26.6 | 1.21 | 185538 | 6.69179938 | CS |
| 260 | -27.63 | -92.1 | 30 | 32.99 | 1.21 | 180233 | 7.72672465 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
